Tatyana Golovkina to Superantigens
This is a "connection" page, showing publications Tatyana Golovkina has written about Superantigens.
Connection Strength
0.774
-
Initial stages of mammary tumor virus infection are superantigen independent. J Immunol. 2004 May 01; 172(9):5582-7.
Score: 0.212
-
Diverse repertoire of the MHC class II-peptide complexes is required for presentation of viral superantigens. J Immunol. 2001 Feb 15; 166(4):2244-50.
Score: 0.170
-
Mouse mammary tumor viruses with functional superantigen genes are selected during in vivo infection. Proc Natl Acad Sci U S A. 1995 May 23; 92(11):4828-32.
Score: 0.114
-
The mouse mammary tumor virus envelope gene product is required for superantigen presentation to T cells. J Exp Med. 1994 Feb 01; 179(2):439-46.
Score: 0.104
-
Unique resistance of I/LnJ mice to a retrovirus is due to sustained interferon gamma-dependent production of virus-neutralizing antibodies. J Exp Med. 2003 Jan 20; 197(2):233-43.
Score: 0.049
-
B and T cells are required for mouse mammary tumor virus spread within the mammary gland. J Immunol. 1998 Sep 01; 161(5):2375-82.
Score: 0.036
-
Generation of a tumorigenic milk-borne mouse mammary tumor virus by recombination between endogenous and exogenous viruses. J Virol. 1997 May; 71(5):3895-903.
Score: 0.033
-
Differences in the avidity of TCR interactions with a superantigenic ligand affect negative selection but do not allow positive selection. J Immunol. 1995 Dec 01; 155(11):5115-23.
Score: 0.030
-
Mouse mammary tumor virus-induced tumorigenesis in sag transgenic mice: a laboratory model of natural selection. J Virol. 1993 Dec; 67(12):7690-4.
Score: 0.026